Disclosure by Pfizer of COVID-19 vaccine readout now unlikely by month’s end

Weeks after Pfizer’s Albert Bourla had suggested a pivotal efficacy readout for its COVID-19 vaccine was likely by the end of October, the chairman and CEO is now signaling that an announcement probably won’t come until next month at the earliest.

An application for an emergency use authorization from FDA would likely come in mid-to-late November, Bourla said on the pharma’s earnings call Tuesday...